Bangkok--Jul 5--Ogilvy Public Relations Worldwide
Schering (Bangkok) Ltd., the leader in oral contraceptives, stresses the leadership in the contraceptive market with the launch of its latest innovative contraceptive among the pharmacies in response to consumers’ needs for birth control, as well as concerns on taking care of their skin and figure, as well as relieving pre-menstrual symptoms (PMS). The new oral contraceptive is a new alternative choice for today’s female consumers concerned about their health and lifestyle.
Mr. Prakarn Kunothai, Sales & Marketing Director of Schering (Bangkok) Ltd., said: “According to the research on women all over the world including Thai women , around one third of all women always face pre-menstrual symptoms such as anxiety, exhaustion, depression, insomnia, and mood swingd. These symptoms affect their lives. work efficiency, as well as social relationships. Some women knew that such effects are caused by pre-menstrual symptoms while others didn’t know why. Therefore, contraceptives, which are now created and developed to have additional benefits addressing these undesirable pre-menstrual symptoms, will be a new alternative choice for these women to have a better quality of life.”
The new oral contraceptive is the low-dose pill with the progestogen hormone developed by Schering to perfectly meet the requirements of consumers who prefer the least side effects as well as enjoy certain health and beauty benefits. In skincare, it helps reduce acne, oiliness of the skin and hairiness. In weight, it relieves the body liquid dilation due to hormone imbalance. More importantly, this is the first contraceptive which helps reduce pre-menstrual symptoms and best suits “the new-generation lively women who are conscious about their health and lifestyle, challenge-loving and engaged in various roles; both working and family”.
The new oral contraceptive researched and developed by the company was distributed in Europe since 2001 and was extremely successful with millions of users. In Thailand, the new oral contraceptive was distributed in leading hospitals under doctors’ recommendations since 2002, and is as well-accepted by doctors and consumers as in Europe because of its birth control efficiency, additional benefits as well as low side effects. In order to expand the distribution channels to respond to consumers’ needs, the company will distribute the new oral contraceptive to pharmacies throughout the country starting July 2004.
“After the launch of the new oral contraceptive among in the pharmacies throughout the country, I expect that by the end of 2004, Schering will be able to increase its market share to 75% in the high-priced oral contraceptives market. At present, the high-priced oral contraceptive represents two thirds of the whole oral contraceptives market, as most consumers, especially new-generation women not only take oral contraceptives for birth control but take it as well for additional benefits. With the special benefits of the new oral contraceptive, it may be the alternative choice for non-consumers. We are truly confident that the new oral contraceptive will generate higher profits for the company,” Mr.Prakarn said.
“The strong revenue of Schering is a result of our firm intent to develop high quality and highly effective oral contraceptives which cater to different consumers’ needs and lifestyles. In addition, Schering is the organization with an important role in developing Thai oral contraceptives, with the cooperation of the Ministry of Public Health’s Department of Health, encouraging people to learn more about contraception, as well as holding medical seminars for pharmacies to earn more about the oral contraceptives’ benefits and enable them to rightly prescribe those contraceptives to consumers.” Mr.Prakarn added.
For the sales promotion of the new oral contraceptives, the company will focus on educating medical professionals particularly pharmacists about PMS in order that the pharmacists will be able to prescribe the new oral contraceptive properly. This time, the company will hold a grand seminar in Bangkok and in four regions of Thailand, in addition to the educational roadshows for pharmacies throughout the country. For consumers, the company will also provide adequate information on and create a better understanding about on pre-menstrual symptoms and its long term effects on themselves and others, in order to enable them to tackle and adapt to this problem appropriately which will lead to a better quality of life.
Issued on behalf of : Schering (Bangkok) Ltd.
For further information : Kanittha Girdhirun
([email protected])
Pangkwan Lekhyananda
([email protected])
Ogilvy Public Relations Worldwide Ltd.
Tel. 0 2632 8300-7 End.
--InfoQuest (NT)--